[SCIENTX] YoY TTM Result on 30-Apr-2020 [#3]

Stock
[SCIENTX] SCIENTEX BERHAD
Announcement Date
23-Jun-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2020
Quarter
30-Apr-2020 [#3]
Profit Trend
QoQ- -0.85%
YoY- 32.19%
Quarter Report
Latest QR
Upcoming QR
SCIENTX's Result
SCIENTX's Financial Summary
View:
Show?
TTM Result
30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 30/04/17 CAGR
Revenue 4,116,676 3,844,387 3,640,231 3,502,737 3,041,835 2,539,678 2,318,143 10.03%
PBT 596,677 549,248 610,640 536,647 380,912 339,044 303,593 11.91%
Tax -125,254 -99,295 -124,272 -128,805 -84,388 -61,029 -62,335 12.32%
NP 471,423 449,953 486,368 407,842 296,524 278,015 241,258 11.80%
-
NP to SH 448,231 427,544 456,631 381,464 288,582 273,646 237,881 11.13%
-
Tax Rate 20.99% 18.08% 20.35% 24.00% 22.15% 18.00% 20.53% -
Total Cost 3,645,253 3,394,434 3,153,863 3,094,895 2,745,311 2,261,663 2,076,885 9.82%
-
Net Worth 3,350,297 3,039,959 2,806,576 2,434,938 2,123,822 1,716,132 1,340,141 16.49%
Dividend
30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 30/04/17 CAGR
Div 155,103 139,570 129,087 103,113 99,823 96,922 50,820 20.42%
Div Payout % 34.60% 32.64% 28.27% 27.03% 34.59% 35.42% 21.36% -
Equity
30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 30/04/17 CAGR
Net Worth 3,350,297 3,039,959 2,806,576 2,434,938 2,123,822 1,716,132 1,340,141 16.49%
NOSH 1,551,063 1,550,999 1,550,594 515,876 515,261 488,926 463,716 22.28%
Ratio Analysis
30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 30/04/17 CAGR
NP Margin 11.45% 11.70% 13.36% 11.64% 9.75% 10.95% 10.41% -
ROE 13.38% 14.06% 16.27% 15.67% 13.59% 15.95% 17.75% -
Per Share
30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 30/04/17 CAGR
RPS 265.41 247.87 234.76 678.99 597.25 519.44 499.90 -10.01%
EPS 28.90 27.57 29.45 73.94 56.66 55.97 51.30 -9.11%
DPS 10.00 9.00 8.33 20.00 19.60 20.00 10.96 -1.51%
NAPS 2.16 1.96 1.81 4.72 4.17 3.51 2.89 -4.73%
Adjusted Per Share Value based on latest NOSH - 515,876
30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 30/04/17 CAGR
RPS 264.52 247.03 233.91 225.07 195.46 163.19 148.96 10.03%
EPS 28.80 27.47 29.34 24.51 18.54 17.58 15.29 11.12%
DPS 9.97 8.97 8.29 6.63 6.41 6.23 3.27 20.40%
NAPS 2.1528 1.9534 1.8034 1.5646 1.3647 1.1027 0.8611 16.49%
Price Multiplier on Financial Quarter End Date
30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 30/04/17 CAGR
Date 28/04/23 29/04/22 30/04/21 30/04/20 30/04/19 30/04/18 28/04/17 -
Price 3.41 3.81 4.19 8.30 8.55 7.61 8.29 -
P/RPS 1.28 1.54 1.78 1.22 1.43 1.47 1.66 -4.23%
P/EPS 11.80 13.82 14.23 11.22 15.09 13.60 16.16 -5.10%
EY 8.47 7.24 7.03 8.91 6.63 7.35 6.19 5.36%
DY 2.93 2.36 1.99 2.41 2.29 2.63 1.32 14.20%
P/NAPS 1.58 1.94 2.31 1.76 2.05 2.17 2.87 -9.46%
Price Multiplier on Announcement Date
30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 30/04/17 CAGR
Date 20/06/23 13/06/22 23/06/21 23/06/20 26/06/19 20/06/18 20/06/17 -
Price 3.41 3.47 4.26 8.77 8.56 6.71 8.34 -
P/RPS 1.28 1.40 1.81 1.29 1.43 1.29 1.67 -4.33%
P/EPS 11.80 12.59 14.47 11.86 15.11 11.99 16.26 -5.20%
EY 8.47 7.94 6.91 8.43 6.62 8.34 6.15 5.47%
DY 2.93 2.59 1.95 2.28 2.29 2.98 1.31 14.35%
P/NAPS 1.58 1.77 2.35 1.86 2.05 1.91 2.89 -9.56%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment